Description
BSE Notice 20260408-21 announces the listing of new securities of ASTAL LABORATORIES LIMITED on the Equity segment effective April 8, 2026.
Summary
BSE Notice No. 20260408-21 dated April 8, 2026 announces the listing of new securities of ASTAL LABORATORIES LIMITED on the Equity segment. This is a standard listing notification issued by the Listing Operations department under the Company Related category.
Key Points
- Notice No.: 20260408-21
- Date: April 8, 2026
- Company: ASTAL LABORATORIES LIMITED
- Segment: Equity
- Department: Listing Operations
- Category: Company Related
- No attachments associated with this notice
Regulatory Changes
No regulatory changes introduced. This is a routine administrative listing notice.
Compliance Requirements
Market participants and brokers should update their records to reflect the listing of new securities of ASTAL LABORATORIES LIMITED on the BSE Equity segment.
Important Dates
- Notice Date: April 8, 2026
- Listing effective as per the notice date: April 8, 2026
Impact Assessment
Limited market impact. This notice pertains solely to the listing of new securities for ASTAL LABORATORIES LIMITED and does not affect broader market operations or trading rules. Investors interested in this company should note the availability of new securities on the BSE Equity segment.
Impact Justification
Routine listing notice for new securities of a single company; no regulatory changes or broad market impact.